Show Summary Details
Page of

DMARDs and immunosuppressive drugs 

DMARDs and immunosuppressive drugs
DMARDs and immunosuppressive drugs
Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 31 May 2020

Methotrexate 532

Sulfasalazine 538

Leflunomide 540

Anti-malarials (hydroxychloroquine and chloroquine) 544

Gold: intramuscular (sodium aurothimalate) and oral (auranofin) 546

Penicillamine 550

Azathioprine 552

Mycophenolate mofetil 556

Ciclosporin (previously cyclosporin A) 558

Cyclophosphamide 562

Biologics: anti-TNF (infliximab, etanercept, adalimumab), anti-CD20 (rituximab), anti-IL-1 (anakinra), CTLA4–Ig (abatacept), and anti-IL-6R (tocilizumab) ...

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.